Serial 97255444
Live / Applied — Fifth extension granted (statement of use) (as of 18 Dec 2025)
What this means for you
Not registered yet, but its 07 Feb 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97255444
- Mark type
- Design / logo
- Filed
- 07 Feb 2022
- Published for opposition
- 03 Jan 2023
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of neurodegenerative, neuroinflammatory, neuromuscular, neurooncological, psychiatric, neurodevelopmental, neurometabolic, ophthalmologic, and central nervous system diseases and disorders
- Class 042 — Scientific and technological services: pharmaceutical research and development services
Owner
- Leal Therapeutics, Inc., Worcester, MA, US
- Leal Therapeutics, Inc., Worcester, MA, US
Prosecution history
- 19 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Dec 2025 — SOU EXTENSION 5 GRANTED
- 30 Jul 2025 — SOU EXTENSION 5 FILED
- 18 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Feb 2025 — SOU EXTENSION 4 GRANTED
- 19 Feb 2025 — SOU EXTENSION 4 FILED
- 19 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Aug 2024 — SOU EXTENSION 3 GRANTED
- 08 Aug 2024 — SOU EXTENSION 3 FILED
- 08 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 19 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jan 2024 — SOU EXTENSION 2 GRANTED